Goldman Sachs Upgrades Qiagen NV (QGEN) to Neutral

Article Stock Quotes (1) Comments (0)

Goldman Sachs upgraded Qiagen NV (NASDAQ: QGEN) from Sell to Neutral with a price target of $17.00 (from $15.00).

The firm cited: 1) we now view FY2012 guidance and Street estimates as reasonable, (2) believe HPV headwinds are better understood, and (3) now incorporate an M&A ranking in our price target methodology as we expect M&A premiums in Diagnostics to persist.

For an analyst ratings summary and ratings history on Qiagen NV click here. For more ratings news on Qiagen NV click here.

Shares of Qiagen NV closed at $16.70 yesterday, with a 52 week range of $12.47-$19.75.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Goldman Sachs Upgrades Enbridge (ENB) to Conviction Buy
• Morgan Stanley Maintains Bullish Stance on Walter Energy (WLT)
• Goldman Sachs Removes Williams Companies (WMB) from CL Buy List; Downgrades Williams Partners (WPZ) to Neutral

Create E-mail Alert Related Categories

Upgrades

Related Entities

Goldman Sachs

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?